Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Jerky protein homolog (JRK) is a conserved nuclear protein structurally related to DNA-binding proteins such as the centromere-binding protein B (CENPB)[3][11]. It contains a helix-turn-helix DNA-binding motif and may act as a transcription factor or gene regulator. Disruption of the related gene in mice leads to recurrent seizures similar to human idiopathic generalized epilepsy, and the human gene is considered a candidate locus for epilepsy such as childhood absence epilepsy[2][3]. JRK is also implicated in tumorigenesis by promoting Wnt pathway hyperactivation and is reportedly overexpressed in various cancer types[1]. Alternative splicing produces multiple transcript variants. There is no current evidence of drugs directly targeting JRK or use as a clinical biomarker, and safety concerns specific to therapeutic manipulation of this protein are not documented in the literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Jerky protein homolog (JRK).